Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm’s products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
You May Also Like
A debt-ceiling deal will spark a new worry: Who will buy the deluge of Treasury bills?
When the U.S. debt-ceiling fight finally is resolved, the Treasury is expected…
- ReportWire
- May 23, 2023
The untold history of the horse in the American Plains, a new future for the world
Newswise — “Horses have been part of us since long before other…
- ReportWire
- March 30, 2023
Timothy Weah receives praise from Brazil great Pele after scoring debut goal against Wales
Brazil legend Pele congratulated United States forward Timothy Weah for scoring a…
- ReportWire
- November 22, 2022
Celtics suspend coach Ime Udoka for 2022-23 season
BOSTON (AP) — The Boston Celtics have suspended Ime Udoka for a…
- ReportWire
- September 23, 2022